Weisman Harlan F 4
4 · TFF Pharmaceuticals, Inc. · Filed Mar 13, 2023
Insider Transaction Report
Form 4
Weisman Harlan F
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
[F1]2023-03-10$0.88/sh+150,000$131,835→ 214,615 total
Footnotes (1)
- [F1]The reported shares were purchased in the open market in one transaction at the price of $0.8789.
Signature
/s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact|2023-03-13